Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

Note 5. Leases

MEDITECH follows the provisions of ASC 842, Leases, which requires improved disclosure on timing and uncertainties of cash flow arising from leases. MEDITECH owns all 8 facilities it occupies, containing 1.1 million square feet of office space. MEDITECH occupies 87% of the space and the remainder is leased to various tenants. All are operating leases. There have been no material changes from the leasing arrangements as discussed in the Company's 2019 financial statements.

Lease income was $2.0 million and $1.1 million for the 3 months ended on March 31, 2019 and March 31, 2020 respectively. Such income is included within Other Income for financial reporting purpose. Cash Flow projections through the end of all outstanding lease terms for properties currently under lease commitment at March 31, 2020 is as follows:

Year	Cash Flow
2020	4,024,000
2021	1,457,000
2022	222,000
2023	44,000
After	0

Investments in Operating leases are as follows at March 31, 2020:

Building and Office Space, at cost	$28,951,486
Lease Origination Costs	170,496
Accumulated Depreciation	(9,537,161)
Net Investment in Operating Leases	$19,584,821